journal article·2018-12-10

Fatty Acid Esters of G0-(Propyl Ether Imine) Dendron as Bicephalous Heterolipids for Permeation Enhancement in Transdermal Drug Delivery

Kapil S. Chaudhari, Krishnacharya G. Akamanchi

Publisher page

Abstract

The objective of the present study was to synthesize, evaluate, and explore the potential of a new class of bicephalous heterolipids (BHLs) as chemical permeation enhancers (CPEs) with emphasis on investigation of the influence of variable chain lengths of BHLs with the G0-PETIM (poly(propyl ether imine)) dendron as a headgroup on skin permeation efficiency using diclofenac sodium (DS) as a model drug. These BHLs were synthesized, and chemical structures were confirmed by FT-IR, 1H NMR, 13C NMR, and ESI-MS. All BHLs were assessed for in vitro cytotoxicity and in vivo skin irritation studies that revealed their dermal safety. All respective DS gels with loaded BHLs were evaluated for skin permeation at varied concentrations, where gels with 1% concentration showed a significant increase in steady state flux (ERflux) as compared to the control gel and oleic acid loaded gel. The mechanism of enhanced skin permeation using BHL-loaded DS gels was examined using transepithelial electrical resistance (TEER), attenuated total reflection infrared (ATIR), and histomorphology, which showed significant reduction in the barrier integrity, alterations in the stratum corneum (SC), and compromising of the SC. These observations were concurrent with skin permeation results indicating that BHL enhancers could have wide scope as semisynthetic CPEs for transdermal drug delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Polydiacetylene-based materials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga (E), Mumbai, India, 400019

Funding

Department of Science and Technology, Ministry of Science and Technology

References (64)

Show source-provided references
1. 10.1016/j.mattod.2013.09.00210.1016/j.mattod.2013.09.002 ↗
2. 10.5507/bp.2001.00810.5507/bp.2001.008 ↗
3. 10.1021/jz200163410.1021/jz2001634 ↗
4. 10.1016/j.tifs.2016.06.00310.1016/j.tifs.2016.06.003 ↗
5. Amir, R. J.; Buzhor, M.; Harnoy, A. J.; Rosenbaum, I.; Frid, L. Agrochemical Delivery System Based on Enzyme or pH- Responsive Amphiphilic PEG-Dendron Hybrids. WO2016038596A1, 2016.
6. 10.1016/j.ejpb.2006.12.00410.1016/j.ejpb.2006.12.004 ↗
7. 10.1073/pnas.050117610210.1073/pnas.0501176102 ↗
8. 10.1038/pj.2012.3910.1038/pj.2012.39 ↗
9. 10.1016/j.jconrel.2014.04.04710.1016/j.jconrel.2014.04.047 ↗
10. 10.1039/C5TB00664C10.1039/C5TB00664C ↗
11. 10.1021/ja806912a10.1021/ja806912a ↗
12. 10.1016/j.ejmech.2011.06.02610.1016/j.ejmech.2011.06.026 ↗
13. 10.1016/j.polymer.2012.04.04710.1016/j.polymer.2012.04.047 ↗
14. 10.1073/pnas.141849411210.1073/pnas.1418494112 ↗
15. 10.1021/acs.langmuir.5b0018310.1021/acs.langmuir.5b00183 ↗
16. 10.1002/adfm.20130325310.1002/adfm.201303253 ↗
17. Hong, S.; Yang, Y. Transdermal Drug Delivery Using Amphiphilic Dendron-Coil Micelles. WO 2014130846A1, 2014.
18. Nian WU, B. C. K. Highly Monodisperse Branched PEG-Lipid Conjugates. WO 2012122144A1, 2012.
19. 10.1039/C4RA01334D10.1039/C4RA01334D ↗
20. 10.1016/j.biomaterials.2007.12.01710.1016/j.biomaterials.2007.12.017 ↗
21. 10.1021/acsami.6b1550510.1021/acsami.6b15505 ↗
22. 10.1021/nn400343z10.1021/nn400343z ↗
23. 10.1002/anie.20120392010.1002/anie.201203920 ↗
24. Small D. M. · J. Lipid Res. · 1984 · 25 · 149010.1016/S0022-2275(20)34422-9 ↗
25. 10.1007/978-3-662-47039-810.1007/978-3-662-47039-8 ↗
26. 10.1007/978-3-662-45013-010.1007/978-3-662-45013-0 ↗
27. 10.1016/j.ijpharm.2013.02.04010.1016/j.ijpharm.2013.02.040 ↗
28. 10.1002/jps.2181710.1002/jps.21817 ↗
29. 10.3109/03639045.2015.104784710.3109/03639045.2015.1047847 ↗
30. 10.1007/978-3-662-47862-210.1007/978-3-662-47862-2 ↗
31. 10.1016/0002-9343(86)90076-810.1016/0002-9343(86)90076-8 ↗
32. Diclofenac Sodium: Drug Information. https://www.drugs.com/monograph/diclofenac-sodium.html (Accessed on March 1, 2017).
33. 10.3109/10717544.2014.92306210.3109/10717544.2014.923062 ↗
34. 10.1016/j.ijpharm.2006.10.04110.1016/j.ijpharm.2006.10.041 ↗
35. 10.1016/j.colsurfb.2017.03.04010.1016/j.colsurfb.2017.03.040 ↗
36. 10.3109/03639045.2014.89295810.3109/03639045.2014.892958 ↗
37. 10.1016/j.ijpharm.2013.07.02810.1016/j.ijpharm.2013.07.028 ↗
38. 10.1021/jo00349a02810.1021/jo00349a028 ↗
39. 10.1002/anie.19690981110.1002/anie.196909811 ↗
40. 10.1038/sj.gt.330045410.1038/sj.gt.3300454 ↗
41. Stability Testing of New Drug Substances and Products Q1A(R2); International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 2003; No. 6, February, pp 1–17. For the revised guidelines web access portal at http://www.ich.org/products/guidelines/quality/quality-single/article/stability-testing-of-new-drug-substances-and-products.html (Accessed on May 8, 2016).
42. 10.1038/nprot.2006.17910.1038/nprot.2006.179 ↗
43. 10.1093/jnci/82.13.110710.1093/jnci/82.13.1107 ↗
44. Guidelines for the Testing of Chemicals. Acute Dermal Irritation/Corrosion. OECD Guidel. Test. Chem. Sect. 4 Heal. Eff.; OECD, 2015; No. July 28th, pp 1–8. Web access at http://www.oecd-ilibrary.org/environment/test-no-404-acute-dermal-irritationcorrosion_9789264242678-en (accessed on January 15, 2015).
45. Draize, J. H. Dermal Toxicity Appraisal of the Safety of Chemicals in Foods, Drugs, and Cosmetics; Association of Food & Drug Officials of the United States: Austin, TX, 1965; pp 49–52.
46. Griffin W. C. · J. Soc. Cosmet. Chem. · 1954 · 5 · 249
47. Davies J. T. · 1957
48. Griffin W. C. · J. Soc. Cosmet. Chem. · 1949 · 1 · 311
49. 10.1023/A:101582060067210.1023/A:1015820600672 ↗
50. 10.1016/S0887-2333(97)00015-510.1016/S0887-2333(97)00015-5 ↗
51. 10.1007/BF0247874110.1007/BF02478741 ↗
52. 10.1016/j.tiv.2004.01.00310.1016/j.tiv.2004.01.003 ↗
53. 10.1016/j.tiv.2003.10.00410.1016/j.tiv.2003.10.004 ↗
54. 10.1007/s11095-008-9696-y10.1007/s11095-008-9696-y ↗
55. 10.1016/j.ijpharm.2016.05.00410.1016/j.ijpharm.2016.05.004 ↗
56. 10.1016/0168-3659(91)90116-U10.1016/0168-3659(91)90116-U ↗
57. 10.1016/S0378-5173(97)00142-710.1016/S0378-5173(97)00142-7 ↗
58. 10.1002/jrs.125023111310.1002/jrs.1250231113 ↗
59. 10.1016/S0168-3659(96)01613-610.1016/S0168-3659(96)01613-6 ↗
60. 10.1016/S0168-3659(96)01618-510.1016/S0168-3659(96)01618-5 ↗
61. 10.1021/jf025653910.1021/jf0256539 ↗
62. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
63. 10.1016/0923-1811(94)90085-X10.1016/0923-1811(94)90085-X ↗
64. 10.1016/j.chemolab.2012.05.01310.1016/j.chemolab.2012.05.013 ↗